Juliette F. Preston
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Juliette F. Preston has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Bettina Dunkel
Clinical Science and Services, The Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield AL9 7TA, UK
2 shared publications Maria-Christine Fischer
The Royal Veterinary College Department of Clinical Science and Services
1 shared publication- Maria-Christine Fischer
Queen Mother Hospital for Animals, Royal Veterinary College, London, UK
1 shared publication Minna P. Mustikka
Helsingin yliopisto Elainlaaketieteellinen tiedekunta Kliinisen hevos- ja pienelainlaaketieteen osasto
1 shared publication- Minna Pauliina Mustikka
Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland
1 shared publication - Simon Lawrence Priestnall
Royal Veterinary College, London, UK
1 shared publication
Latest Publications
- Open Access
- 26 August 2024
- Published by Wiley in Equine Veterinary Journal
- Vol. 57 (3) , 598-610
Clinical features and outcomes of horses presenting with presumed equine immune mediated keratitis to two veterinary hospitals in the United Kingdom and Finland : 94 cases (2009–2021)
Background: There is limited literature regarding equine immune mediated keratitis (IMMK) in Europe. North America‐based publications describe minimal blepharospasm, rare corneal ulceration and no uveitis; clinical impression suggests these are seen in Europe. Objectives: Assess the prevalence of blepharospasm, corneal ulceration and uveitis and their impact on outcome in horses diagnosed with IMMK in Europe (UK and Finland). Study design: Retrospective case series. Methods: Clinical records of 94 horses with IMMK were evaluated. The UK and Finland populations were comparable; therefore, descriptive statistics were performed on combined data on subtypes of IMMK and clinical features. Odds ratios (OR) and confidence intervals (CI) were calculated for impact of blepharospasm, ulceration or presence of uveitis on the outcome of enucleation and treatment duration. Results: IMMK subtype was classified as 10/94 (10.6%) epithelial, 50/94 (53.2%) anterior stromal, 14/94 (14.9%) mid‐stromal, 4/94 (4.25%) endothelial and 16/94 (17.0%) unrecorded. After excluding three horses with incidental corneal ulceration, blepharospasm was documented in 34/91 (37.4%), corneal ulceration in 26/91 (28.6%), and signs of uveitis in 23/91 (25.3%) horses. Increased odds of enucleation were significantly associated with the presence of blepharospasm (OR 5.5, 95% CI 1.6–19.4, p = 0.008) and signs of uveitis (OR 8.9, 95% CI 2.6–30.8, p < 0.001), but not corneal ulceration. The presence of blepharospasm, corneal ulceration or uveitis did not significantly alter the odds of ongoing medication. Main limitations: Data were collected over a wide timeframe; the diagnosis was mainly made without histopathology; a broad definition of uveitis was used and there was a bias towards complicated cases being retained for follow‐up. Conclusions: The clinical features of IMMK were similar between two European countries but differed to USA descriptions. Blepharospasm, corneal ulceration and signs of uveitis can occur with IMMK; presence of blepharospasm and uveitis increase the odds of enucleation.
- 26 August 2024
- Published by Wiley in Equine Veterinary Journal
- Vol. 57 (3) , 598-610
Open AccessClinical features and outcomes of horses presenting with presumed equine immune mediated keratitis to two veterinary hospitals in the United Kingdom and Finland : 94 cases (2009–2021)
Background: There is limited literature regarding equine immune mediated keratitis (IMMK) in Europe. North America‐based publications describe minimal blepharospasm, rare corneal ulceration and no uveitis; clinical impression suggests these are seen in Europe. Objectives: Assess the prevalence of blepharospasm, corneal ulceration and uveitis and their impact on outcome in horses diagnosed with IMMK in Europe (UK and Finland). Study design: Retrospective case series. Methods: Clinical records of 94 horses with IMMK were evaluated. The UK and Finland populations were comparable; therefore, descriptive statistics were performed on combined data on subtypes of IMMK and clinical features. Odds ratios (OR) and confidence intervals (CI) were calculated for impact of blepharospasm, ulceration or presence of uveitis on the outcome of enucleation and treatment duration. Results: IMMK subtype was classified as 10/94 (10.6%) epithelial, 50/94 (53.2%) anterior stromal, 14/94 (14.9%) mid‐stromal, 4/94 (4.25%) endothelial and 16/94 (17.0%) unrecorded. After excluding three horses with incidental corneal ulceration, blepharospasm was documented in 34/91 (37.4%), corneal ulceration in 26/91 (28.6%), and signs of uveitis in 23/91 (25.3%) horses. Increased odds of enucleation were significantly associated with the presence of blepharospasm (OR 5.5, 95% CI 1.6–19.4, p = 0.008) and signs of uveitis (OR 8.9, 95% CI 2.6–30.8, p < 0.001), but not corneal ulceration. The presence of blepharospasm, corneal ulceration or uveitis did not significantly alter the odds of ongoing medication. Main limitations: Data were collected over a wide timeframe; the diagnosis was mainly made without histopathology; a broad definition of uveitis was used and there was a bias towards complicated cases being retained for follow‐up. Conclusions: The clinical features of IMMK were similar between two European countries but differed to USA descriptions. Blepharospasm, corneal ulceration and signs of uveitis can occur with IMMK; presence of blepharospasm and uveitis increase the odds of enucleation.
- Open Access
- 14 March 2024
- Published by Wiley
Clinical features and outcomes of horses presenting with equine immune mediated keratitis (IMMK) to two veterinary hospitals in the United Kingdom and Finland: 96 cases (2009-2021).
Background: Limited literature exists regarding equine Immune Mediated Keratitis (IMMK) in Europe. North America-based publications describe minimal blepharospasm, rare corneal ulceration and no uveitis; clinical impression suggests that these signs are common in Europe. Objectives. Assess the prevalence of blepharospasm, corneal ulceration and uveitis and their impact on outcome in horses diagnosed with IMMK in European countries. Study design: Retrospective case series of 95 horses with IMMK in the UK and Finland. Methods. Clinical records of horses with IMMK were retrospectively evaluated. The UK and Finland populations were comparable; therefore, descriptive statistics were performed on combined data on subtypes of IMMK and clinical features. Odds ratios (OR) and confidence intervals (CI) were calculated for impact of blepharospasm, ulceration or presence of uveitis on the outcome of enucleation and treatment duration. Results. IMMK subtype was classified as 10/95 (10.5%) epithelial, 50/95 (52.6%) anterior stromal, 15/95 (15.8%) mid-stromal, 4/95 (4.2%) endothelial cases and 16/19 (16.8%) unrecorded. Blepharospasm was documented in 35/95 (36.8%), corneal ulceration in 28/95 (29.5%), and signs of uveitis in 24/95 (25.4%) of horses. Increased odds of enucleation were associated with the presence of blepharospasm (OR 5.9, 95% CI 1.7-20.8), corneal ulceration (OR 3.3, 95% CI 1.0-10.5) and signs of uveitis (OR 8.6, 95% CI 2.5-29.6). The presence of blepharospasm, corneal ulceration or uveitis did not significantly alter the odds of ongoing medication. Main limitations: Data were collected over a wide timeframe and the diagnosis was mainly made without histopathology. A broad definition of uveitis was used and there was a bias towards complicated cases being retained for follow up. Conclusions . The clinical features of IMMK were similar between two geographically distinct European countries but different to findings described in the USA. Blepharospasm, corneal ulceration and signs of uveitis can occur with IMMK and increase the odds of enucleation.
- 14 March 2024
- Published by Wiley
Open AccessClinical features and outcomes of horses presenting with equine immune mediated keratitis (IMMK) to two veterinary hospitals in the United Kingdom and Finland: 96 cases (2009-2021).
Background: Limited literature exists regarding equine Immune Mediated Keratitis (IMMK) in Europe. North America-based publications describe minimal blepharospasm, rare corneal ulceration and no uveitis; clinical impression suggests that these signs are common in Europe. Objectives. Assess the prevalence of blepharospasm, corneal ulceration and uveitis and their impact on outcome in horses diagnosed with IMMK in European countries. Study design: Retrospective case series of 95 horses with IMMK in the UK and Finland. Methods. Clinical records of horses with IMMK were retrospectively evaluated. The UK and Finland populations were comparable; therefore, descriptive statistics were performed on combined data on subtypes of IMMK and clinical features. Odds ratios (OR) and confidence intervals (CI) were calculated for impact of blepharospasm, ulceration or presence of uveitis on the outcome of enucleation and treatment duration. Results. IMMK subtype was classified as 10/95 (10.5%) epithelial, 50/95 (52.6%) anterior stromal, 15/95 (15.8%) mid-stromal, 4/95 (4.2%) endothelial cases and 16/19 (16.8%) unrecorded. Blepharospasm was documented in 35/95 (36.8%), corneal ulceration in 28/95 (29.5%), and signs of uveitis in 24/95 (25.4%) of horses. Increased odds of enucleation were associated with the presence of blepharospasm (OR 5.9, 95% CI 1.7-20.8), corneal ulceration (OR 3.3, 95% CI 1.0-10.5) and signs of uveitis (OR 8.6, 95% CI 2.5-29.6). The presence of blepharospasm, corneal ulceration or uveitis did not significantly alter the odds of ongoing medication. Main limitations: Data were collected over a wide timeframe and the diagnosis was mainly made without histopathology. A broad definition of uveitis was used and there was a bias towards complicated cases being retained for follow up. Conclusions . The clinical features of IMMK were similar between two geographically distinct European countries but different to findings described in the USA. Blepharospasm, corneal ulceration and signs of uveitis can occur with IMMK and increase the odds of enucleation.